MedTrace Logo

IV Iron Versus Standard Treatment for Iron Deficiency Anemia in the Emergency Department

NCT05153278 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2022-03-24

No results posted yet for this study

Summary

The investigators will retrospectively collect data of patients infused at UMC's emergency department (ED) with long acting irons (ferric carboxymaltose, iron dextran, iron sucrose, etc.), in addition, patients infused with blood products, with intent to treat iron deficiency anemia (IDA). Patient records reviewed will be from patients who were infused at UMC ED from January 2013 to June 2018. Primary aim of analysis will be to investigate superiority between interventions implemented for treating IDA. In addition, the investigators will utilize data to characterize patients who used ED services as an avenue to receive treatment for IDA. Further, the investigators will conduct cost analysis between different IDA directed treatments administered in the ED at UMC.

Conditions

  • Iron Deficiency Anemia Treatment
  • Iron-deficiency
  • Iron Deficiency Anemia Due to Blood Loss
  • Iron Deficiency Anemia

Interventions

BIOLOGICAL

Packed red blood cells

Standard treatment for iron deficiency anemia (control)

DRUG

Intravenous drug

Experimental treatment for iron deficiency treatment

Sponsors & Collaborators

  • Texas Tech University Health Sciences Center, El Paso

    lead OTHER

Principal Investigators

  • Gregory Patek, MD · Texas Tech University Health Sciences Center, El Paso

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-26
Primary Completion
2020-08-26
Completion
2020-08-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05153278 on ClinicalTrials.gov